These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 2680945)
1. Metabolism of transplacental carcinogens. Anderson LM; Jones AB; Miller MS; Chauhan DP IARC Sci Publ; 1989; (96):155-88. PubMed ID: 2680945 [TBL] [Abstract][Full Text] [Related]
2. Modification of transplacental tumorigenesis by 3-methylcholanthrene in mice by genotype at the Ah locus and pretreatment with beta-naphthoflavone. Anderson LM; Jones AB; Riggs CW; Kovatch RM Cancer Res; 1989 Apr; 49(7):1676-81. PubMed ID: 2538231 [TBL] [Abstract][Full Text] [Related]
3. Expression of glutathione S-transferases in fetal lung and liver tissue from parental strains and F1 crosses between C57BL/6 and BALB/c F1 mice following in utero exposure to 3-methylcholanthrene. Xu M; Moore JE; Leone-Kabler S; McCoy TP; Swank A; Nelson GB; Ross JA; Townsend AJ; Miller MS Biochem Pharmacol; 2006 Jun; 72(1):115-23. PubMed ID: 16678797 [TBL] [Abstract][Full Text] [Related]
4. Reduction in the transplacental carcinogenic effect of methylcholanthrene in mice by prior treatment with beta-naphthoflavone. Anderson LM; Priest LJ Res Commun Chem Pathol Pharmacol; 1980 Dec; 30(3):431-46. PubMed ID: 7255859 [TBL] [Abstract][Full Text] [Related]
5. Protection against tumorigenesis by 3-methylcholanthrene in mice by beta-naphthoflavone as a function of inducibility of methylcholanthrene metabolism. Anderson LM; Seetharam S Cancer Res; 1985 Dec; 45(12 Pt 1):6384-9. PubMed ID: 4063988 [TBL] [Abstract][Full Text] [Related]
6. Strain-dependent differences in the metabolism of 3-methylcholanthrene by maternal, placental, and fetal tissues of C57BL/6J and DBA/2J mice. George JD; Manson JM Cancer Res; 1986 Nov; 46(11):5671-5. PubMed ID: 3756914 [TBL] [Abstract][Full Text] [Related]
8. Oocyte destruction by polycyclic aromatic hydrocarbons is not linked to the inducibility of ovarian aryl hydrocarbon (benzo(a)pyrene) hydroxylase activity in (DBA/2N X C57BL/6N) F1 X DBA/2N backcross mice. Mattison DR; Nightingale MS Pediatr Pharmacol (New York); 1982; 2(1):11-21. PubMed ID: 7110752 [TBL] [Abstract][Full Text] [Related]
9. Fetal mouse susceptibility to transplacental carcinogenesis: differential influence of Ah receptor phenotype on effects of 3-methylcholanthrene, 12-dimethylbenz[a]anthracene, and benzo[a]pyrene. Anderson LM; Ruskie S; Carter J; Pittinger S; Kovatch RM; Riggs CW Pharmacogenetics; 1995 Dec; 5(6):364-72. PubMed ID: 8747408 [TBL] [Abstract][Full Text] [Related]
10. Age-, tissue-, and Ah genotype-dependent differences in the binding of 3-methylcholanthrene and its metabolite(s) to mouse DNA. Lu LJ; Harvey RG; Lee H; Baxter JR; Anderson LM Cancer Res; 1990 Jul; 50(14):4239-47. PubMed ID: 2364382 [TBL] [Abstract][Full Text] [Related]
11. Fetal mouse susceptibility to transplacental lung and liver carcinogenesis by 3-methylcholanthrene: positive correlation with responsiveness to inducers of aromatic hydrocarbon metabolism. Anderson LM; Jones AB; Riggs CW; Ohshima M Carcinogenesis; 1985 Sep; 6(9):1389-93. PubMed ID: 4028336 [TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics and human cancer. Nebert DW IARC Sci Publ; 1982; (39):365-80. PubMed ID: 7152614 [TBL] [Abstract][Full Text] [Related]
13. Genetically mediated induction of drug-metabolizing enzymes associated with congenital defects in the mouse. Lambert GH; Nebert DW Teratology; 1977 Oct; 16(2):147-53. PubMed ID: 412268 [TBL] [Abstract][Full Text] [Related]
14. The formation of 3-methylcholanthrene-initiated lung tumors correlates with induction of cytochrome P450IA1 by the carcinogen in fetal but not adult mice. Miller MS; Jones AB; Park SS; Anderson LM Toxicol Appl Pharmacol; 1990 Jun; 104(2):235-45. PubMed ID: 2363175 [TBL] [Abstract][Full Text] [Related]
15. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245 [TBL] [Abstract][Full Text] [Related]
16. 32P-postlabeling assay in mice of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl, and benzo(a)pyrene. Lu LJ; Disher RM; Reddy MV; Randerath K Cancer Res; 1986 Jun; 46(6):3046-54. PubMed ID: 3698023 [TBL] [Abstract][Full Text] [Related]
17. Role of the maternal environment in determining susceptibility to transplacentally induced chemical carcinogenesis in mouse fetuses. Miller MS; Jones AB; Chauhan DP; Anderson LM Carcinogenesis; 1990 Nov; 11(11):1979-84. PubMed ID: 1699680 [TBL] [Abstract][Full Text] [Related]
18. Gene expression, ontogeny and transplacental induction of hepatic UDP-glucuronosyl transferase activity in mice. Chauhan DP; Miller MS; Owens IS; Anderson LM Dev Pharmacol Ther; 1991; 16(3):139-49. PubMed ID: 1914788 [TBL] [Abstract][Full Text] [Related]
19. Mouse lung tumors exhibit specific Ki-ras mutations following transplacental exposure to 3-methylcholanthrene. Wessner LL; Fan M; Schaeffer DO; McEntee MF; Miller MS Carcinogenesis; 1996 Jul; 17(7):1519-26. PubMed ID: 8706258 [TBL] [Abstract][Full Text] [Related]
20. Prenatal toxicity and lack of carcinogenicity of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) following transplacental exposure. Gressani KM; Leone-Kabler S; O'Sullivan MG; Townsend AJ; Miller MS Toxicol Sci; 2000 Jun; 55(2):407-14. PubMed ID: 10828274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]